Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024

Go back to Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
(NASDAQ: SPRB) Delayed: 43.37 +1.92 (4.63%)
Previous Close $41.45    52 Week High
Open $41.99    52 Week Low
Day High $43.49    P/E N/A 
Day Low $41.99    EPS
Volume 59,130